Aharon Schwartz, Director at Protalix BioTherapeutics, Inc. (PLX), bought 129,000 shares at $1.60 ($206K) on 2025-06-10, disclosed to the SEC on 2025-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| FOMX | BUY | 2018-12-06 | $438K | — | Filing → |